IFPMA launches Note for Guidance to help those acting on behalf of biopharmaceutical companies live up to its ethical business principles

The International Association of Pharmaceutical Manufacturers and Associations (IFPMA) published today a Note for Guidance on how to foster ethical relationshipswith third party intermediaries in the biopharmaceutical sector. IFPMA’s mission rests on the establishment and promotion of ethical principles for the industry as a whole and anyone acting on its behalf, in line with societal…

A journey through the history of vaccines

The possibility of eradicating a disease that has killed thousands of people is one of the great achievements of humanity. Vaccines revolutionized medicine forever. And if we talk about these, we must talk about the so-called “father of immunology”, the Englishman Edward Jenner, who lived between the 18th and 19th centuries. When Jenner was young,…

Safely developing COVID-19 treatments

As the months pass, the pharmaceutical industry is facing new challenges to stop the COVID-19 pandemic. Currently, treatments under study, clinical trials taking place around the world and plans for accelerating the treatments and vaccines manufacture, are some of the main issues around the world. It is clear that approved vaccines will solve the problem…